Benzoxazole kinase inhibitors and methods of use

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8476431
APP PUB NO 20100190749A1
SERIAL NO

12586241

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides chemical entities, compounds and pharmaceutical compositions thereof that are capable of modulating certain protein kinases such as mTor, tyrosine kinases, and/or lipid kinases such as PI3 kinase. For example, the invention provides compounds of Formula:

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
FAETH THERAPEUTICS INC701 TILLERY STREET #12 #1010 AUSTIN TX 78702

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chan, Katrina San Diego, US 65 3044
Li, Liansheng San Diego, US 158 5429
Liu, Yi San Diego, US 838 10296
Ren, Pingda San Diego, US 198 6390
Wilson, Troy Edward San Marino, US 58 2079

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 2, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00